FDA

FDA guidance provides new details on diversity action plans required for certain studies

U.S. FDA shared a post on X:

“Today, Food and Drug Administration issued a draft guidance to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies.”

Devika Das, Medical Director at Parexel shared on X adding:

“Let us design and run trials that are equitable towards all of the population they are meant to serve. FDA issued guidance from today.”

FDA guidance provides new details on diversity action plans required for certain studies

Source: U.S. FDA/X and Devika Das/X

cancer Devika Das diversity action plans FDA Food and Drug Administration OncoDaily Oncology parexel U.S. FDA